Version: 12
Who needs to follow 21 CFR part 11 compliance?
Anyone conducting a clinical trial that uses electronic records in place of paper records, including electronic signatures that are intended to be the equivalent of handwritten signatures.
Definitions
Electronic Consent: in the scope of REDCap, electronic consent refers to the electronic capture of a ‘wet' signature from a participant using the e-consent framework. This requirement covers the ‘Electronic Signature’ definition found in the FDA part 11 regulations.
...
Electronic Signature (E-Signature): in the scope of REDCap, an E-signature refers to the individual verifying the data being captured electronically, digitally signing, and authenticating their identity. This requirement covers the ‘Digital Signature’ definition found in the FDA part 11 regulations.
...
View the FDA Title 21 Chapter I Subchapter A Part 11 regulations here.
User Rights
Security features that limit user access and their privileges must be in place. Some examples of these security features include making sure users have unique usernames and passwords, being able to detect and prevent unauthorized system access, and locking compromised accounts, and utilizing the Data Resolution Workflow.
The three primary tools for enforcing limited system access:
User passwords to access a system
Two-factor authentication during log in (DUO)
Program time-outs which lock the system when not in use for an extended period of time (30 minutes)
|
Relevant Resource: https://utahctsi.atlassian.net/servicedesk/customer/portal/3/article/276988105?src=543000090
Go to Next Page, or return to Table of Contents